Synthesis of glutamic acid analogs as potent inhibitors of leukotriene A(4) hydrolase

Thomas A. Kirkland, Marc Adler, John G. Bauman, Ming Chen, Jesper Z. Haeggstrom, Beverly King, Monica J. Kochanny, Amy M. Liang, Lisa Mendoza, Gary B. Phillips, Marjolein Thunnissen, Lan Trinh, Marc Whitlow, Bin Ye, Hong Ye, John Parkinson, William J. Guilford

Research output: Contribution to journalArticlepeer-review

Abstract

Leukotriene B-4 (LTB4) is a potent pro-inflammatory mediator that has been implicated in the pathogenesis of multiple diseases, including psoriasis, inflammatory bowel disease, multiple sclerosis and asthma. As a method to decrease the level of LTB4 and possibly identify novel treatments, inhibitors of the LTB4 biosynthetic enzyme, leukotriene A(4) hydrolase (LTA(4)-h), have been explored. Here we describe the discovery of a potent inhibitor of LTA(4)-h, arylamide of glutamic acid 4f, starting from the corresponding glycinamide 2. Analogs of 4f are then described, focusing on compounds that are both active and stable in whole blood. This effort culminated in the identification of amino alcohol 12a and amino ester 6b which meet these criteria.
Original languageEnglish
Pages (from-to)4963-4983
JournalBioorganic & Medicinal Chemistry
Volume16
Issue number9
DOIs
Publication statusPublished - 2008

Subject classification (UKÄ)

  • Biological Sciences

Free keywords

  • leukotriene A4
  • inhibitor
  • crystal structure

Fingerprint

Dive into the research topics of 'Synthesis of glutamic acid analogs as potent inhibitors of leukotriene A(4) hydrolase'. Together they form a unique fingerprint.

Cite this